The Pharmaceutical Industry Labor-Management Association (PILMA) and the California Biopharmaceutical Industry Labor-Management Association (CBPILMA) hosted an event at the Democratic Governors Association’s conference in Beverly Hills highlighting how investing in high skilled labor supports 21st century pharmaceutical innovation.
Partnership Between Pharmaceutical Industry and Labor Creates Good Jobs
The partnership between the biopharmaceutical industry and labor unions fosters a collaborative environment that keeps each side innovating. Training programs equip union workers with the skills to build and maintain state-of-the-art facilities providing industry with the capability to discover life-saving cures.
Pharmaceutical-Labor Alliance Flourishes
The AFL-CIO Blog highlights the value of the PILMA coalition: “One staple of PILMA’s program—along with conferences and other get-togethers—is to provide tours of union training facilities, which allow industry officials to see firsthand the skill levels and training union workers bring to the specialized construction needs of the biotechnology industry.” Read the Full Article
PILMA Chairman Issues Statement on Legislative Proposals that would Harm Innovation and Jobs
On January 16, 2019, Eric Dean, General President of the International Association of Bridge, Structural, Ornamental and Reinforcing Iron Workers and Chairman of PILMA issued the following statement on legislative proposals that would negatively impact innovation and jobs. View the statement in PDF. The biopharmaceutical industry supports more than 4.7 million American jobs. Significant investment in capital […]
New PILMA Study Shows Partnership Drives $14B in Construction
December 13, 2018 Today, PILMA in partnership with the Institute for Construction Economic Research (ICERES) released a first of its kind report quantifying the economic impact of the partnership between the building trades unions and the biopharmaceutical industry. Main takeaways include: The partnership between skilled craft unions and biopharmaceutical companies helped drive $14 billion in construction investment […]
PILMA Statement on HHS Speech and its Impact on Innovation and Union Jobs
On October 25, 2018, PILMA released the following statement in response to President Trump’s speech at the Department of Health and Human Services. The statement follows a previously adopted PILMA Resolution on Price Controls. View the statement in PDF. The labor unions and biopharmaceutical companies of the Pharmaceutical Industry Labor-Management Association (PILMA) have a longstanding […]